Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Survey on hypersensitivity reactions associated with modified folfox-6 therapy for outpatients

  • In: Hospital Pharmacy - Posters
  • At: Basel (Switzerland) (2008)
  • Type: Poster
  • Poster code: HPS-P-113
  • By: KIMURA, Masayuki (Department of Pharmacy Services, Saitama Med. Center, Saitama Med. University, Kawagoe, Saitama 350-8550, Japan)
  • Co-author(s): Sano, Motohiko (Department of Pharmacy Services, Saitama Med. Center, Saitama Med. University, KAWAGOE, SAITAMA 350-8550, Japan)
    Inoue, Naohiko (Department of Pharmacy Services, Saitama Med. Center, Saitama Med. University, KAWAGOE, SAITAMA 350-8550, Japan)
    Maruyama, Misaki (Outpatient Chemotherapy Division, Japan)
    Nakazawa, Takae (Outpatient Chemotherapy Division, Japan)
    Shimada, Hiromi (Outpatient Chemotherapy Division, Japan)
    Nagai, Fusako (Outpatient Chemotherapy Division, Japan)
    Okada, Norimichi (Department of Digestive Tract and General Surgery, Japan)
    Ishibashi, Keiichiro (Department of Digestive Tract and General Surgery, Japan)
    Ishida, Hideyuki (Department of Digestive Tract and General Surgery, Japan)
    Nakamura, Fusako (Department of Pharmacy,Satsukikai Ogasawara Clinic, Japan)
  • Abstract:

    OBJECTIVE:FOLFOX regimens including oxaliplatin (L-OHP) are widely used in patients with metastatic colorectal cancer in Japan. Hypersensitivity reactions (HRs) associated with L-OHP is one of the major adverse events in FOLFOX regimens. However, the incidence of HRs has not been fully clarified in Japanese patients. So, we tried to survey..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses